European Medicines Agency - Regulatory - Regulation of medicines
GENERAL INFORMATION
  Company name: Brilitas Pharmaceuticals EU OÜ  
  Address: Pärnu mnt 139c , Harju maakond, Kesklinna linnaosa, 11317 Tallinn, Estonia  
  Web: Brilitas.com    
  Company creation date: 2022   
  Employees: 11   
  Field of activity: Human/Veterinary   
  Record last updated on: 08/03/2023   
CONTACT DETAILS
  Contact name: Dang Tran Quang   
  Tel: +84 888 332 899   
  Fax:    
  Email: info-ee@brilitas.com   
COMPANY SECTOR  
(Bio)Pharmaceutical:    
  Early manufacturing/Research&Discovery stage:  
  Development stage:  
  Commercialisation/Marketing stage (EU/Non-EU):  
Medical Device and Technology:    
  Development stage:  
  Commercialisation/Marketing stage (EU/Non-EU):  
PRODUCT INFORMATION  
Medicinal Products      
  Vaccines:  
  Therapeutic medicines:  
  Diagnostic and imaging products:  
  Combined medicinal products and devices:  
Product Development Stages    
Number of Products
  Research/Discovery:
  Pharmaceutical development:
  Preclinical:
  Clinical exploratory:
  Clinical confirmatory:
  (Pre)registration (EU/Non-EU):
 
  Marketing (EU/Non-EU):
 
SUBSTANCES
Chemicals    
  Single entities  
  Combinations of single entities  
 Peptides (chemically synthesised)  
Biologically derived proteins and peptides  
  Monoclonal antibodies  
  Recombinant proteins  
  Extracted proteins  
Nucleic acids (chemically synthesised)  
  RNA  
  DNA  
Polymer (natural and synthetic - excluding peptides, proteins and nucleic acids)  
  Homopolymers  
  Copolymers  
Advanced therapy medicinal products (in accordance with EC 1394/2007)  
  Somatic cell therapy products  
  Tissue engineered products  
  Gene therapy products  
Radionuclides    
Allergens    
Polyclonal immunoglobulins  
Herbal derived complex substances  
Animal derived complex substances  
SPECIFIC PRODUCT CATEGORIES
  Biodefense  
  Biosimilars  
  Excipients  
  Foods (Functional foods, nutraceuticals)  
  Generics  
  Genetically modified organisms (GMOs)  
  Homeopathics  
  Maximum Residue Limits (Veterinary products)  
  Medical devices  
  Medicines for tropical diseases  
  MUMS (Minor Use/Minor Species) /Limited Market (Veterinary products)  
  Nanotechnology (including microparticles, liposomes, microbeads)  
  New formulations/delivery methods  
  Orphan medicines (in accordance with Orphan Drug Regulation EC/141/2000)  
  OTC (Over the counter)/Non prescription/self medication  
  Paediatric medicines  
  Stem cells  
 Theranostics (personalised/targeted products, biomarkers,(pharmaco)genomics)  
  Transgenic technology  
THERAPEUTIC AREA (assigned or expected ATC codes)
  A Alimentary tract and metabolism  
  B Blood and blood forming organs  
  C Cardiovascular system  
  D Dermatologicals  
  G Genito-urinary system and sex hormones  
  H Systemic hormonal preparations, excluding sex hormones  
  J General anti-infectives for systemic use  
  L Anti-neoplastic and immunomodulating agents  
  M Musculo-skeletal system  
  N Nervous system  
  P Anti-parasitic products, Insecticides, Repellents  
  R Respiratory system  
  S Sensory organs  
  V Various  
 
Back to list